Physician profile
Brian D Le
NPI 1235138306
$101,930.16
in general payments reported to CMS, 2019-2025
33 companies · $1,077 in 2025
The $1,077 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41K · 2020: $14K · 2021: $22K · 2022: $6,053 · 2023: $8,202 · 2024: $9,854 · 2025: $1,077.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,625 · Food and Beverage: $5,619 · Travel and Lodging: $3,589 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,625.00 |
| Food and Beverage | $5,618.60 |
| Travel and Lodging | $3,588.85 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $35,007.73 | 2019-2025 | Emblem Mri S-Icd, Bodyguardian, Farapulse |
| Janssen Pharmaceuticals, INC | $28,750.11 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $14,133.32 | 2019-2025 | Eliquis, Camzyos |
| Pfizer INC. | $9,435.88 | 2019-2025 | |
| Abbott Laboratories | $7,994.26 | 2019-2025 | Aveir, Assurity, Gallant |
| Sanofi-Aventis U.S. LLC | $1,748.96 | 2019-2024 | |
| Medtronic, INC. | $1,234.97 | 2021-2024 | Micra, Azure Xt Dr Mri Surescan |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,136.81 | 2019-2025 | Lifevest |
| Impulse Dynamics (USA) INC. | $624.34 | 2020-2025 | Optimizer, Optimizer |
| Aop Health US, LLC | $274.80 | 2025 | Rapiblyk |
| Abiomed | $223.25 | 2022-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $220.87 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $206.54 | 2021-2024 | Verquvo |
| Shockwave Medical, INC | $125.97 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Respicardia, INC. | $87.94 | 2023 | Remede System |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $86.23 | 2024-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Amgen INC. | $79.05 | 2021-2023 | Repatha |
| Kestra Medical Technology Services, INC. | $75.00 | 2025 | Assure Wcd |
| Medtronic Vascular, INC. | $70.41 | 2019-2020 | |
| Kiniksa Pharmaceuticals, Ltd. | $52.57 | 2023 | Arcalyst |
| Philips North America LLC | $48.53 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $43.86 | 2022-2024 | |
| Cardiofocus, INC. | $43.72 | 2019 | |
| Stryker Corporation | $39.62 | 2025 | Clottriever Bold Catheter |
| Altathera Pharmaceuticals LLC | $39.25 | 2020-2025 | Sotalol Hydrochloride |
| Nalu Medical, INC. | $31.84 | 2024 | Nalu Neurostimulation System |
| Teleflex LLC | $21.94 | 2025 | Pk Papyrus |
| Depuy Synthes Sales INC. | $18.94 | 2024 | Matrixrib |
| Heartflow, INC. | $17.59 | 2022 | |
| Terumo Medical Corporation | $15.51 | 2019 | |
| Baxter Healthcare | $14.89 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Angiodynamics, INC. | $13.20 | 2022 | |
| Bardy Diagnostics, INC. | $12.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.